General Range

Cysdaz-A

Novalab Healthcare Pvt. Ltd.Panchkula, Haryana

Cysdaz-A Tablets by Novalab Healthcare Pvt. Ltd. contain Acebrophylline and Acetylcysteine, a combination of respiratory medicines intended for the management of selected conditions involving excessive mucus production, airway narrowing and chest congestion.

Acebrophylline is a xanthine-derived medicine with bronchodilator and mucus-regulating properties. It may help relax bronchial smooth muscles and support the clearance of respiratory secretions in patients with certain obstructive airway conditions.

Acetylcysteine is a mucolytic agent that works by breaking disulfide bonds within mucus proteins, reducing mucus viscosity and making respiratory secretions easier to clear from the airways.

Cysdaz-A Tablets may be prescribed for selected patients with chronic obstructive pulmonary disease (COPD), chronic bronchitis and other respiratory conditions involving thick mucus when combination treatment is clinically appropriate.

The formulation is intended for ongoing respiratory symptom management and is not suitable for immediate relief from an acute asthma attack.

Cysdaz-A Tablets should be taken strictly according to a registered medical practitioner's prescription. Dosage and treatment duration depend on the patient's respiratory condition, medical history and treatment response.

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.